Metabolic effects of atazanavir/ritonavir vs darunavir/ritonavir in combination with tenofovir/emtricitabine in antiretroviral-na ve patients (ATADAR Study)

View

000320654200049.pdf (169.0Kb)

Identifiers

URI: http://hdl.handle.net/20.500.13003/12979

DOI: 10.7448/IAS.15.6.18202

eISSN: 1758-2652

WOS ID: 000320654200049

Embase PUI: L71227629

Metrics

10.7448/IAS.15.6.18202

 

 

Share

Export

External links

Statistics

Item usage statistics

Metadata

Show Dublin Core item record

Author

Martinez, E.; Gonzalez-Cordon, A.; Podzamczer, D.; Domingo, P.; Negredo, E.; Gutierrez, F.; Portilla, J.; Ribera, E.; Murillas Angoiti, Javier; Arribas, J.; Santos, I; Carton, J.; Peraire, J.; Pich, J.; Perez, I; Gatell, J.; ATADAR Team

Publication date

2012-11

Document type

contribution to journal

Citation

Martinez E, Gonzalez-Cordon A, Podzamczer D, Domingo P, Negredo E, Gutierrez F, et al. Metabolic effects of atazanavir/ritonavir vs darunavir/ritonavir in combination with tenofovir/emtricitabine in antiretroviral-na ve patients (ATADAR Study) [meeting abstract]. J Int AIDS Soc. 2012 Nov;15:22-3.

Publisher version

https://dx.doi.org/10.7448/IAS.15.6.18202

This item appears in following Docusalut collections

Hospital Universitario Son Espases - HUSE > Comunicación científica